Mesothelioma Cancer Resources Blog

Source: CancerMonthly.com Virotherapy is a rapidly-evolving treatment regimen where viruses are engineered to replicate only in certain types of tumor cells and to specifically attack only those cells. The difficulty is designing a virus with the proper molecular composition to target only certain types of cancer cells, such as those involved with mesothelioma, while ignoring …

Source: News-Medical.Net Researches from the Ireland Cancer Center have discovered a mutation in the epidermal growth factor protein (EGFR) that causes resistance in lung cancer cells to targeting agents, such as Tarceva, that attempt to halt the spread of cancer cells by disrupting the receptor responsible for tumor growth. Tarceva has been successfully deployed in …

Source: Rosetta Genomics The NYU Medical Center, one of the world’s premier academic medical institutions, has partnered with Rosetta Genomics, a leader in the development of microRNA-based diagnostics and therapeutics, to jointly-develop early detection diagnostic tools for lung cancer and mesothelioma. Dr. Harvey Pass, Professor and Chief of the Division of Thoracic Surgery and Thoracic …

Source: Billings Gazette Libby, Montana is the location of what the EPA calls “the worst case of community-wide exposure to a toxic substance in U.S. history.” One of Libby’s major revenue sources was its vermiculite mine, but in 1990 it was discovered that the mine was contaminated with asbestos and that this contamination had exposed …

Source: Cancer Monthly Mesothelioma with conventional treatment has a median survival rate of 9 to 12 months after diagnosis, which is one of the worst survival rates of any cancer. Yet, there are examples in the medical literature of patients who’ve lived much longer than this after their diagnosis. Doctors and researchers do not understand …

Source: PRWeb Paul Kraus is an inspiration to many victims of mesothelioma. He was diagnosed with mesothelioma in 1997 and only given months to live. Now, 10 years later, he is still alive and well and still giving speeches on his journey. He has even written a highly-regarded book, Surviving Mesothelioma and Other Cancers: A …

Source: StarNewsOnline.com This article profiles Glen Long, a mesothelioma survivor who has responded favorably to his treatment regimen. Mr. Long was diagnosed with mesothelioma in 2006 and has completed a series of chemotherapy treatments. His cancer has since stabilized and he notes that he’s been able to return to some of this activities.

Source: Barbara Ann Karmanos Cancer Institute Scientists from the Barbara Ann Karmanos Cancer Institute, one of the major cancer research centers in the United States, announced significant results in their latest research into the treatment of malignant pleural mesothelioma. Karmanos researches studying the ubiquitin-proteasome proteolytic (UPP) pathway determined that protein ubiquitination and degradation are essential …

Source: eMaxHealth The Minnesota Department of Health (MDH) is embarking on two long-term studies of mining activities in the northeastern part of the state. The first study will be a detailed account of the health of mine workers in the region. There have been over 50 diagnoses of mesothelioma among people who worked these mines …

Source: BusinessWire European developer and marketer CISBIO has announced that the U.S. Food and Drug Administration (FDA) has approved MESOMARK® Assay, the first in-vitro test for managing patients with mesothelioma, for use. The test is now available for monitoring patients who suffer from epithelioid or biphasic mesothelioma. The introduction of a minimally invasive monitoring agent …